Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sherry

Showing results (211-220 of 252) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4Kimberly E Beck, Joseph A Blansfield, Khoi Q Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Ophthalmology|May 5, 2009
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanomaSteven Yeh, Neel K Karne, Sid P Kerkar, et al.
Transplantation and Cellular Therapy|November 19, 2022
Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft SourceBrian H Johnstone, John R Woods, W Scott Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2021
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic MelanomaSamantha J Seitter, Richard M Sherry, James C Yang, et al.
Annals of Surgical Oncology|September 25, 2009
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapyR Taylor Ripley, Jeremy L Davis, Jacob A Klapper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanomaSteven A Rosenberg, James C Yang, Douglas J Schwartzentruber, et al.
Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.
Pageof 26

Showing results (211-220 of 252) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2006
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4Kimberly E Beck, Joseph A Blansfield, Khoi Q Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2003
Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigensGiao Q Phan, Christopher E Touloukian, James C Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2018
A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus-associated Epithelial CancersSanja Stevanović, Sarah R Helman, John R Wunderlich, et al.
Ophthalmology|May 5, 2009
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanomaSteven Yeh, Neel K Karne, Sid P Kerkar, et al.
Transplantation and Cellular Therapy|November 19, 2022
Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft SourceBrian H Johnstone, John R Woods, W Scott Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2021
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic MelanomaSamantha J Seitter, Richard M Sherry, James C Yang, et al.
Annals of Surgical Oncology|September 25, 2009
Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapyR Taylor Ripley, Jeremy L Davis, Jacob A Klapper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2003
Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanomaSteven A Rosenberg, James C Yang, Douglas J Schwartzentruber, et al.
Journal of Pharmaceutical Sciences|April 12, 2011
PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approachRagini Vuppugalla, Punit Marathe, Handan He, et al.
Pageof 26